Latest Posts

• Will 3-D Thermal Imaging Revolutionize Breast Cancer Detection?

  Paul Angott is an idea man. He holds 40 patents on products such as a clock thermostat, a wireless doorbell, and a laser-guided, unmanned mower for football fields and golf courses. Throughout his career, he’s launched five companies and raised more than $10 million... Read more »

  Sarah Schmid5/18/12

  • Detroit

  • medical devices

  • innovation

  • startups

• Misery Loves Company: 38 Studios, AEB, and WFNX

  OK, listening to Morphine’s “Cure for Pain” on Julie Kramer’s very last Leftover Lunch show on WFNX pushed me over the edge. In case you missed the news amid all the Facebook hoopla, Boston alternative music station WFNX is being bought... Read more »

  Gregory T. Huang5/18/12

  • Boston

  • Technology

  • startups

  • Closures

• Can Facebook’s New Millionaires Save the World?

  To whom much is given, much shall be required.

  Regular readers know that I’m not in the habit of quoting scripture. But this line found in the gospels of Matthew, Mark, and Luke has a bit of new relevance this morning, as Facebook’s... Read more »

  Wade Roush5/18/12

  • wwwade

  • IT

  • startups

• For Those on Watch, Hope Springs Eternal as Hair Trials Inch Along

  Waiting for the biotech industry to advance new treatments for male pattern baldness (as well as female hair loss) might seem about as exciting as watching hair grow. But some people have a lot of skin in the game, if you know... Read more »

  Bruce V. Bigelow5/18/12

  • San Diego

  • Hair Loss

  • Baldness

  • Hair Regrowth

• CardioKinetix Clears 2-Year Study with Implant for Heart Failure

  CardioKinetix has spent 10 years and $80 million in venture capital working on an implantable device for people with heart failure. Now it’s got some evidence that suggests it could be on track with a real product.

  The Menlo Park, CA-based company is... Read more »

  Luke Timmerman5/18/12

  • San Francisco

  • Biotech

  • Devices

  • Heart Failure

• Promedior, Aveo, Ra, and More Boston Life Sciences Headlines

  Drugs, devices, and nonprofits showed up in this week’s New England life sciences news.

  —Promedior, a maker of treatments for tissue damage known as fibrosis, is moving its headquarters from Pennsylvania to Boston and has hired Suzanne Bruhn, a veteran of the Irish drug... Read more »

  Erin Kutz5/18/12

  • Boston

  • Life Sciences

  • Roundup

  • Drugs

• Think Tech Labs Tailors Salesforce to the Real Estate Market

  Yesterday, we published an article about why VC guru Jason Mendelson is feeling bullish about Michigan as a hub for entrepreneurship. He pointed out that the state’s tendency toward collaboration is an important asset that should continue to be championed. Vijay Mehra,... Read more »

  Sarah Schmid5/17/12

  • Detroit

  • startups

  • IT

  • Software

Read More Posts ›